{
    "code": "41000034",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=41000034",
    "time": "2020-02-26 03:14:19",
    "許可證字號": "衛署藥陸輸字第000034號",
    "註銷狀態": "已註銷",
    "註銷日期": "105\/05\/30",
    "註銷理由": "許可證已逾有效期",
    "製造許可登錄編號": "",
    "有效日期": "102\/12\/08",
    "發證日期": "92\/12\/08",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA04100003402",
    "中文品名": "&quot;凱利&quot; 希美替定",
    "英文品名": "&quot;KAILI&quot; CIMETIDINE",
    "適應症": "組織胺H2接受體拮抗劑。",
    "劑型": "040（粉）",
    "包裝": "０．５公斤以上",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "01製劑原料",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CIMETIDINE",
    "限制項目": "02輸　入 40大陸生產",
    "申請商名稱": "0516401100  世強化學製藥股份有限公司",
    "申請商地址": "臺北市中山區松江路72號10樓",
    "主製造廠": [
        {
            "製造廠名稱": "FCN0014000  WUXI KAILI PHARMACEUTICAL CO., LTD.",
            "製造廠廠址": "PENGGAN VILLAGE, ZHOUTIE TOWN, YIXING CITY, JIANGSU PROVINCE, P.R. OF CHINA",
            "製造廠公司地址": "",
            "製造廠國別": "CHINA",
            "製程": ""
        }
    ],
    "CCC號列": "29332900005 其他之結構中含有一未稠合之咪唑環（不論是否氫化）之化合物Other compounds containing an unfused imidazole ring (whether or not hydrogened) in the structure",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5640000500",
            "成分名稱": "CIMETIDINE",
            "含量描述": "(98.0-102.0)",
            "含量": "",
            "單位": "%"
        }
    ]
}